<oembed>
<success>1</success><type>rich</type><version>1.0</version><cache_age type="integer">86400</cache_age><width type="integer">440</width><height type="integer">500</height><provider_name>RiffReporter</provider_name><provider_url>https://www.riffreporter.de</provider_url><safety>nonadult</safety><asset_type>article</asset_type><url>https://www.riffreporter.de/de/wissen/corona-covid19-novavax-totimpfstoff-booster-omikron</url><category>Wissen</category><author_name>Ulrike Gebhardt</author_name><author_url>https://www.riffreporter.de/de/autorinnen-und-autoren/ulrike-gebhardt</author_url><title>Novavax-Impfstoff gegen Covid-19 in Europa zugelassen</title><summary>Das aus Virusproteinen bestehende Vakzin ist eine sinnvolle und dringend notwendige Ergänzung für die Impfkampagne gegen das Coronavirus</summary><publication_date>22.12.2021</publication_date><thumbnail_url>https://riff.media/images/corona-covid-novavax-impfstoff.jpg?w=440&amp;h=247&amp;fit=crop-50-50&amp;s=35ac647db5cb642f4ebf3eff4669c37b</thumbnail_url><thumbnail_width type="integer">440</thumbnail_width><thumbnail_height type="integer">247</thumbnail_height><thumbnail_credit></thumbnail_credit><thumbnail_credit_url></thumbnail_credit_url><thumbnail_credit_note></thumbnail_credit_note><html>&lt;html lang=&quot;de&quot;&gt;&lt;iframe src=&quot;https://riff.media/oembed?format=html&amp;url=https%3A%2F%2Fwww.riffreporter.de%2Fde%2Fwissen%2Fcorona-covid19-novavax-totimpfstoff-booster-omikron&quot; width=&quot;440&quot; height=&quot;550&quot; style=&quot;border: 0; width: 440px; height: 550px;&quot; allowtransparency=&quot;true&quot; allowfullscreen&gt;&lt;/iframe&gt;&lt;/html&gt;</html>
</oembed>
